Great Lakes Retirement Inc. Acquires 73 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Great Lakes Retirement Inc. raised its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 1.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,873 shares of the biotechnology company’s stock after purchasing an additional 73 shares during the quarter. Great Lakes Retirement Inc.’s holdings in Axon Enterprise were worth $1,548,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in AXON. International Assets Investment Management LLC purchased a new position in Axon Enterprise in the third quarter worth about $871,860,000. Private Advisor Group LLC boosted its holdings in shares of Axon Enterprise by 19.8% in the 3rd quarter. Private Advisor Group LLC now owns 12,382 shares of the biotechnology company’s stock worth $4,948,000 after purchasing an additional 2,043 shares during the period. Signaturefd LLC boosted its holdings in shares of Axon Enterprise by 16.3% in the 3rd quarter. Signaturefd LLC now owns 655 shares of the biotechnology company’s stock worth $262,000 after purchasing an additional 92 shares during the period. Sequoia Financial Advisors LLC increased its position in shares of Axon Enterprise by 4.9% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock valued at $690,000 after purchasing an additional 81 shares during the last quarter. Finally, Argus Investors Counsel Inc. raised its holdings in Axon Enterprise by 1.1% during the 3rd quarter. Argus Investors Counsel Inc. now owns 4,543 shares of the biotechnology company’s stock valued at $1,816,000 after buying an additional 51 shares during the period. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Axon Enterprise news, Director Julie A. Cullivan sold 900 shares of the stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $353.53, for a total transaction of $318,177.00. Following the completion of the sale, the director now directly owns 3,653 shares of the company’s stock, valued at approximately $1,291,445.09. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In related news, Director Michael Garnreiter sold 1,000 shares of the business’s stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of $437.98, for a total transaction of $437,980.00. Following the transaction, the director now directly owns 26,259 shares in the company, valued at $11,500,916.82. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Julie A. Cullivan sold 900 shares of the stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $353.53, for a total value of $318,177.00. Following the completion of the sale, the director now owns 3,653 shares of the company’s stock, valued at approximately $1,291,445.09. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 371,172 shares of company stock worth $137,000,162. 6.10% of the stock is owned by corporate insiders.

Axon Enterprise Price Performance

NASDAQ AXON opened at $442.69 on Thursday. The company has a market cap of $33.45 billion, a PE ratio of 116.81, a P/E/G ratio of 12.05 and a beta of 0.94. Axon Enterprise, Inc. has a 52-week low of $199.29 and a 52-week high of $455.17. The company has a debt-to-equity ratio of 0.35, a quick ratio of 2.52 and a current ratio of 2.88. The firm’s 50 day moving average price is $393.29 and its 200-day moving average price is $334.66.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.02 by $0.18. The business had revenue of $504.00 million for the quarter, compared to analysts’ expectations of $478.35 million. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The business’s revenue for the quarter was up 34.5% on a year-over-year basis. During the same quarter last year, the firm earned $0.80 EPS. Sell-side analysts forecast that Axon Enterprise, Inc. will post 1.79 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have weighed in on AXON shares. Robert W. Baird boosted their price objective on shares of Axon Enterprise from $360.00 to $400.00 and gave the company an “outperform” rating in a research report on Tuesday, September 10th. Northland Securities increased their price objective on shares of Axon Enterprise from $330.00 to $365.00 and gave the stock an “outperform” rating in a research report on Thursday, August 8th. Barclays raised their price objective on shares of Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 7th. The Goldman Sachs Group upped their target price on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research note on Wednesday. Finally, Jefferies Financial Group assumed coverage on Axon Enterprise in a report on Wednesday, July 17th. They set a “buy” rating and a $385.00 price objective for the company. Two investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $382.85.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.